The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

ASH Update on Higher-Risk MDS: Efficacy/Safety of Pevonedistat + Azacitidine vs. Azacitidine Alone

119 views
March 5, 2021
Comments 0
Login to view comments. Click here to Login